About
Wave 80 Biosciences develops next-generation molecular diagnostics instruments and consumables for hepatitis C, hepatitis B, HIV/AIDS, and other human health conditions. Distinguished by a novel one patient-one test usage model, best-in-class performance, and a superior value proposition, Wave 80's pipeline products address unmet needs of diverse patient populations worldwide in the high-clinical-value molecular diagnostics segment of the clinical laboratory testing systems market.
Technologies
Outlook
Microsoft Office 365
GoDaddy Hosting
Shutterstock
Mobile Friendly
Varnish
Google Analytics
jPlayer
WordPress.org
Render
Keywords
medical equipment manufacturing
liquid micropiston technology
sample prep technology
assay development
biotechnology
scalable manufacturing
clinical diagnostics
ultrafast kinetics
high-yield sample processing
automated assay systems
respiratory infection diagnosis
high-viscosity sample handling
molecular diagnostics
complex sample matrices
infectious disease testing
viral detection
autoimmune diagnostics
low-resource assay platforms
assay automation
sample preparation
molecular testing
government
services
multiplexed autoantibody detection
medical devices
assay miniaturization
healthcare equipment & supplies
diagnostic assays
infectious disease diagnostics
autoantibody measurement
Company Information
-
Employees 3
-
Founded 2003
-
Annual Revenue $23735000
Location
2325 3rd Street, San Francisco, California, United States, 94107
